Join
Live feed
·
INSIDERFilingvia Quantisnow
Teva Pharmaceutical Industries Limited logo

EVP, Chief Financial Officer Kalif Eliyahu Sharon sold $5,457,375 worth of Ordinary Shares (153,251 units at $35.61) as part of a pre-agreed trading plan, decreasing direct ownership by 47% to 172,184 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TEVA (Teva Pharmaceutical Industries Limited) and more on Quantisnow.